FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Registration Date 23 Apr 2018
Revision Date 23 Apr 2018
Share

Nbelyax®

(0)

Medicine Pharmaceuticals

Drug

Properties

Non-toxic Anti-septic Disinfectant Bioselectivity Neutralisation

Manufacturer's Description

The head of Éviter®'s extraordinary power is Nbelyax®, a unique nano-molecule in the world, developed in Mexico and patented internationally.
Nbeylax®, a new molecule that has been proudly patented in Mexico. In addition, the application has been filed in 148 countries through the PCT (Patent Cooperation Treaty) and 12 other countries directly. It is the first Mexican patent with projection to many countries in the world.

The scientific linkage has been fundamental for the development of technology and its certifications. Without the support of researchers, institutions, laboratories, and universities, such an important discovery would not have been possible, with a number of recognitions and mentions from the press deserving of a nomination by the World Economic Forum.

Nano-matter presents properties completely different from those of the macro scale.
The nano scale redefines possible levels of manipulation of matter against previously known. Controlling their behavior, properties and chemical composition allows different technical applications that would otherwise be unimaginable.

This incredible molecule controls the biological behavior and chemical structure of the microorganism and modifies it in such a way that it loses its pathogenicity.

The manufacturing process of the nano-material, allows to have a contact surface that reaches a linear kilometer of information that reacts with the genetic material.

Advanced studies in biophysics have determined that the cell walls of microorganisms have different magnetic charges than those of animal and plant cells.
Thanks to this discovery and taking advantage of these loads, the active ingredient in Éviter® products is able to select only the pathogens and neutralize them completely.

This selective response is a critical advantage for the administration of the active, since its biocatalyst reacts only on contact with the genetic material, presenting an exponentially greater effectiveness than the common disinfectants.

When it comes into contact with the genetic material, it breaks the molecular bonds, disarticulates its DNA or RNA strand and as there is no transfer of genetic information, the microorganisms do not generate any resistance

In this post-antibiotic era, microbial resistance is closely linked to intrahospital infections, which are the fifth-highest among deaths in developed countries. Eviter thus represents a vigorous infection control technique.

Keeping surfaces (or skin) free of the full spectrum of pathogenic microorganisms, ie viruses, bacteria, fungi, spores, trypanosomes and mycobacteria, is the way we will be able to fight infection.

Through different laboratories authorized by COFEPRIS (regulatory entity) we have confronted the products to the microbial challenge under the methodology of the standard BB-040 against various pathogenic microorganisms. This standard indicates that the pathogen should be removed by 99.99% in a maximum of 30 seconds. We have achieved it in all categories, that is why it has been cataloged with a Total Spectrum effectiveness.